EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Net income

annual net income:

-$133.81M-$33.65M(-33.60%)
December 31, 2024

Summary

  • As of today (September 17, 2025), EWTX annual net profit is -$133.81 million, with the most recent change of -$33.65 million (-33.60%) on December 31, 2024.
  • During the last 3 years, EWTX annual net income has fallen by -$91.00 million (-212.55%).
  • EWTX annual net income is now -1278.80% below its all-time high of -$9.71 million, reached on December 31, 2019.

Performance

EWTX Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

quarterly net income:

-$36.12M+$4.68M(+11.48%)
June 30, 2025

Summary

  • As of today (September 17, 2025), EWTX quarterly net profit is -$36.12 million, with the most recent change of +$4.68 million (+11.48%) on June 30, 2025.
  • Over the past year, EWTX quarterly net income has dropped by -$4.62 million (-14.66%).
  • EWTX quarterly net income is now -1033.91% below its all-time high of -$3.19 million, reached on March 31, 2020.

Performance

EWTX quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

TTM net income:

-$150.70M-$4.62M(-3.16%)
June 30, 2025

Summary

  • As of today (September 17, 2025), EWTX TTM net profit is -$150.70 million, with the most recent change of -$4.62 million (-3.16%) on June 30, 2025.
  • Over the past year, EWTX TTM net income has dropped by -$34.83 million (-30.05%).
  • EWTX TTM net income is now -4631.68% below its all-time high of -$3.19 million, reached on March 31, 2020.

Performance

EWTX TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

EWTX Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-33.6%-14.7%-30.1%
3 y3 years-212.6%-124.8%-167.3%
5 y5 years-1278.8%-813.4%-2011.0%

EWTX Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-212.6%at low-124.8%+11.5%-167.3%at low
5 y5-year-1278.8%at low-813.4%+11.5%-2011.0%at low
alltimeall time-1278.8%at low-1033.9%+11.5%-4631.7%at low

EWTX Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$36.12M(-11.5%)
-$150.70M(+3.2%)
Mar 2025
-
-$40.80M(+2.9%)
-$146.09M(+9.2%)
Dec 2024
-$133.81M(+33.6%)
-$39.66M(+16.2%)
-$133.81M(+7.7%)
Sep 2024
-
-$34.13M(+8.4%)
-$124.29M(+7.3%)
Jun 2024
-
-$31.50M(+10.4%)
-$115.88M(+9.5%)
Mar 2024
-
-$28.52M(-5.4%)
-$105.85M(+5.7%)
Dec 2023
-$100.16M(+48.1%)
-$30.14M(+17.2%)
-$100.16M(+12.0%)
Sep 2023
-
-$25.71M(+19.8%)
-$89.44M(+10.1%)
Jun 2023
-
-$21.47M(-6.0%)
-$81.22M(+7.1%)
Mar 2023
-
-$22.84M(+17.6%)
-$75.82M(+12.1%)
Dec 2022
-$67.64M
-$19.41M(+11.0%)
-$67.64M(+11.0%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$17.50M(+8.9%)
-$60.92M(+8.1%)
Jun 2022
-
-$16.07M(+9.6%)
-$56.37M(+11.3%)
Mar 2022
-
-$14.66M(+15.5%)
-$50.66M(+18.3%)
Dec 2021
-$42.81M(+150.0%)
-$12.70M(-2.0%)
-$42.81M(+42.2%)
Sep 2021
-
-$12.95M(+25.1%)
-$30.12M(+75.4%)
Jun 2021
-
-$10.35M(+51.9%)
-$17.17M(+59.4%)
Mar 2021
-
-$6.82M(+72.4%)
-$10.77M(+50.8%)
Dec 2020
-$17.12M(+76.4%)
-
-
Jun 2020
-
-$3.95M(+24.1%)
-$7.14M(+124.1%)
Mar 2020
-
-$3.19M
-$3.19M
Dec 2019
-$9.71M
-
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual net income year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Edgewise Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. TTM net income year-on-year change?

What is Edgewise Therapeutics, Inc. annual net profit?

The current annual net income of EWTX is -$133.81M

What is the all time high annual net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual net profit is -$9.71M

What is Edgewise Therapeutics, Inc. annual net income year-on-year change?

Over the past year, EWTX annual net profit has changed by -$33.65M (-33.60%)

What is Edgewise Therapeutics, Inc. quarterly net profit?

The current quarterly net income of EWTX is -$36.12M

What is the all time high quarterly net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly net profit is -$3.19M

What is Edgewise Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, EWTX quarterly net profit has changed by -$4.62M (-14.66%)

What is Edgewise Therapeutics, Inc. TTM net profit?

The current TTM net income of EWTX is -$150.70M

What is the all time high TTM net income for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high TTM net profit is -$3.19M

What is Edgewise Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, EWTX TTM net profit has changed by -$34.83M (-30.05%)
On this page